T&R Biofab Co., Ltd. (KOSDAQ:246710)

T&R Biofab Statistics

Total Valuation

T&R Biofab has a market cap or net worth of KRW 51.07 billion. The enterprise value is 93.92 billion.

Market Cap	51.07B
Enterprise Value	93.92B

Important Dates

The last earnings date was Friday, August 22, 2025.

Earnings Date	Aug 22, 2025
Ex-Dividend Date	n/a

Share Statistics

T&R Biofab has 21.55 million shares outstanding.

Current Share Class	21.55M
Shares Outstanding	21.55M
Shares Change (YoY)	n/a
Shares Change (QoQ)	-0.08%
Owned by Insiders (%)	26.75%
Owned by Institutions (%)	5.68%
Float	15.78M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.45
PB Ratio	2.31
P/TBV Ratio	3.10
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-10.85
EV / Sales	6.34
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-6.86

Financial Position

The company has a current ratio of 0.49, with a Debt / Equity ratio of 2.15.

Current Ratio	0.49
Quick Ratio	0.31
Debt / Equity	2.15
Debt / EBITDA	n/a
Debt / FCF	-3.48
Interest Coverage	-3,629.15

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-20.94%
Revenue Per Employee	172.29M
Profits Per Employee	-100.68M
Employee Count	86
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -60.15% in the last 52 weeks. The beta is 0.84, so T&R Biofab's price volatility has been lower than the market average.

Beta (5Y)	0.84
52-Week Price Change	-60.15%
50-Day Moving Average	3,431.60
200-Day Moving Average	4,225.28
Relative Strength Index (RSI)	34.40
Average Volume (20 Days)	283,008

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, T&R Biofab had revenue of KRW 14.82 billion and -8.66 billion in losses. Loss per share was -401.75.

Revenue	14.82B
Gross Profit	3.19B
Operating Income	-11.17B
Pretax Income	-8.66B
Net Income	-8.66B
EBITDA	-7.52B
EBIT	-11.17B
Loss Per Share	-401.75

Balance Sheet

The company has 9.49 billion in cash and 47.62 billion in debt, giving a net cash position of -38.12 billion or -1,769.27 per share.

Cash & Cash Equivalents	9.49B
Total Debt	47.62B
Net Cash	-38.12B
Net Cash Per Share	-1,769.27
Equity (Book Value)	22.14B
Book Value Per Share	807.68
Working Capital	-21.21B

Cash Flow

In the last 12 months, operating cash flow was -11.87 billion and capital expenditures -1.82 billion, giving a free cash flow of -13.69 billion.

Operating Cash Flow	-11.87B
Capital Expenditures	-1.82B
Free Cash Flow	-13.69B
FCF Per Share	-635.24

Margins

Gross margin is 21.50%, with operating and profit margins of -75.41% and -58.43%.

Gross Margin	21.50%
Operating Margin	-75.41%
Pretax Margin	-58.43%
Profit Margin	-58.43%
EBITDA Margin	-50.75%
EBIT Margin	-75.41%
FCF Margin	n/a

Dividends & Yields

T&R Biofab does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-16.96%
FCF Yield	-26.80%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 5, 2022. It was a forward split with a ratio of 2.

Last Split Date	Apr 5, 2022
Split Type	Forward
Split Ratio	2

Scores

T&R Biofab has an Altman Z-Score of -1.74. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.74
Piotroski F-Score	n/a